From the Journals

Low-carb breakfast key to lower glucose variability in T2D?


 

FROM THE AMERICAN JOURNAL OF CLINICAL NUTRITION

Intervention improved CGM measures

There was no significant difference in the primary outcome, change in A1c, at the end of 12 weeks, in the two groups. The mean A1c decreased by 0.3% in the intervention group vs 0.1% in the control group (P = .06).

Similarly, in secondary outcomes, weight and BMI each decreased about 1% and waist circumference decreased by about 2.5 cm in each group at 12 weeks (no significant difference). There were also no significant differences in hunger, satiety, or physical activity between the two groups.

However, the 24-hour CGM data showed that mean and maximum glucose, glycemic variability, and time above range were all significantly lower in participants in the low-carbohydrate breakfast intervention group vs. those in the control group (all P < .05).

Time in range was significantly higher among participants in the intervention group (P < .05).

In addition, the 2-hour postprandial CGM data showed that mean glucose and maximum glucose after breakfast were lower in participants in the low-carbohydrate breakfast group than in the control group.

This work was supported by investigator-initiated operating grants to senior author Jonathan P. Little, PhD, School of Health and Exercise Sciences, University of British Columbia, from the Egg Nutrition Center, United States, and Egg Farmers of Canada. The authors declare that they have no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

The Prediabetes Debate: Should the Diabetes Diagnostic Threshold Be Lowered, Allowing Clinicians to Intervene Earlier?
Type 2 Diabetes ICYMI
What are the healthiest drinks for patients with type 2 diabetes?
Type 2 Diabetes ICYMI
Medications provide best risk-to-benefit ratio for weight loss, says expert
Type 2 Diabetes ICYMI
Expert discusses which diets are best, based on the evidence
Type 2 Diabetes ICYMI
New AACE type 2 diabetes algorithm individualizes care
Type 2 Diabetes ICYMI
CGM completes picture of A1c in type 2 diabetes
Type 2 Diabetes ICYMI
Foot ulcers red flag for eye disease in diabetes
Type 2 Diabetes ICYMI
‘Staggering’ weight loss and benefits in body composition with tirzepatide
Type 2 Diabetes ICYMI
Younger age of type 2 diabetes onset linked to dementia risk
Type 2 Diabetes ICYMI
Diabetes, cholesterol meds use drops after bariatric surgery
Type 2 Diabetes ICYMI